Hemostatic Agents: Market Size & Forecast 2026

The global hemostatic agents market reached approximately USD 7.2 billion in 2025 (base year), growing at a 6.8 percent CAGR through 2032 to reach roughly USD 11.4 billion. The category operates in a structurally supplier-favoring balance: pharmaceutical-grade thrombin feedstock prices at USD 2,850 per metric tonne (US spot, Q2 2026), a Top-3 supplier share we estimate at 55-65 percent, and EU MDR certification lead times of 12-18 months that structurally lock in switching costs. Hospital surgical procedures dominate at 52 percent of end-use demand, while trauma care at 24 percent and military applications at 12 percent represent the faster-growing pockets. EV displacement is not a factor here; hemostatic agents are anchored to surgical procedure volumes, not automotive platforms. > **Analyst Take.** The consensus 6.8 percent CAGR is defensible but runs ahead of the underlying surgical-p

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.